The PDF files of a few abstracts are available throughout the programme. The full collection of the extended abstracts is availble as a hard bound
edition of the Proceedings Book and can be ordered online.
Tuesday 20th November

17.00 - 19.30


Registration
Exhibition set-up
Poster presentations set-up
   and

WELCOME RECEPTION

. .
Wednesday 21st November

7.45 - 8.30
.

Registration/Coffee
.
SESSION I - Auditorium Marcel Jenny
Session Chairman: J.-C. Sanchez, Geneva University Hospital, Switzerland
8.30 - 8.35 Opening remarks (SPS Committee)
8.35 - 8.45 Welcome Address
Prof. P.M. Suter, Dean of the Faculty of Medicine, University of Geneva, Switzerland
8.45 - 9.30 Opening Lecture: Proteomics (and its trends facing nature complexity
D. Hochstrasser, Geneva University Hospital, Geneva, Switzerland
9.30 - 10.15 Historical Opening Lecture: Proteomics: back to the future
R. D. Appel & A. Bairoch, Swiss Institute of Bioinformatics, Geneva, Switzerland
10.15 - 11.00 Keynote Lecture: Proteomics in a Pharma Research Environment
J. Van Oostrum, Functional Genomics, Novartis, Basel, Switzerland
11.00 - 11.15 COFFEE BREAK
11.15 - 11.50 Invited Lecture: Capillary electrophoresis: a powerful analytical tool
J.-L. Veuthey, Laboratory of Pharmaceutical Analytical Chemistry, University of Geneva, Switzerland
11.50 - 12.25 Invited Lecture: Identification of new transporters by a subcellular proteomics approach
J. Garin, CEA - Department of Molecular and Structural Biology, Grenoble, France
12.25 - 13.00 Invited Lecture: Protein phosphorylation: will we have a "holy grail" method for studying it ?
M. Quadroni, Institute of Biochemistry, University of Lausanne, Switzerland
13.00 - 14.00 LUNCH
SESSION II A - Rooms 0911 - 13
14.10 - 15.30

POSTER SESSION
    and
COFFEE BREAK
.

SESSION II B - Room 0914
14.10 - 14.40 Nonlinear Dynamics Tutorial Lecture: Progenesis and Progenera: high-throughput analysis and mining of Proteomic data
I. Sanders, Nonlinear Dynamics Ltd
14.50 - 15.20 Amersham Pharmacia Biotech Tutorial Lecture: DeCyder- Quantitation and Statistical Analysis Using 2D-DIGE
S. David, Amersham Biosciences

SESSION III - Auditorium Marcel Jenny
Session Chairwoman: P. M. Palagi, Swiss Institute of Bioinformatics, Geneva, Switzerland
15:30 - 15:50 Venoms proteomics: Novel approaches for drug discovery
(View Abstract)
Ph. Favreau, Atheris Laboratories, Geneva, Switzerland
15:50 - 16:10 Proteomics of Oryza Sativa
A. Koller, Torrey Mesa Research Institute, San Diego, USA
16:10 - 16:30 Peptidomic and proteomic approaches to investigate the defense reactions in Drosophila melanogaster
(View Abstract)
Ph. Bulet, UPR9022, CNRS, IBMC, Strasbourg, France
16:30 - 16:50 Towards understanding the membrane protein interactions
I. Stagljar, Institute of Vet. Biochemistry and Molecular Biology, University of Zurich-Irchel, Zurich, Switzerland
16:50 - 17:10 MALDI MS-MS with high resolution and sensitivity for identification and characterization of proteins
W. Bienvenut, Geneva University Hospital, LCCC Proteomics Research Group, Geneva, Switzerland
17:10 - 17:30 Visualization and Analysis of Molecular Scanner Peptide Mass Spectra
(View Abstract)
M. Müller, Swiss Institute of Bioinformatics, Geneva, Switzerland

17.30 - 18.30
.

First SPS General Council Meeting
.
20.00 - GALA DINNER
Restaurant des Vieux Grenadiers
Rue de Carouge 92
Geneva

Thursday 22nd November

.


SESSION IV - Marcel Jenny Auditorium
Session Chairman: J. Rossier, Laboratoire d'Electrochimie - DC, EPFL, Lausanne, Switzerland
9.00 - 9.45 Keynote Lecture: Proteomics of Prion diseases
A. Aguzzi, Institute of Neuropathology, Zurich, Switzerland
9.45 - 10.20 Invited Lecture: Functional Proteomics of the Nucleolus
J.-J. Diaz, INSERM, Faculty of Medicine, Lyon, France
10.20 - 10.55 Invited Lecture: Proteomics of heart disease
M. Dunn, National Heart and Lung Institute, Harefield, UK
10.55 - 11.15 COFFEE BREAK
11.15 - 11.35 The CSF detection of the 14-3-3 protein is of limited value in patients with dementia of various causes
P. Burkhard, Clinique et Policlinique de Neurologie, Hôpital Cantonal Universitaire, Geneva, Switzerland
11.35 - 11.55 Proteome approach to study "dome" formation in the LA7 rat mammary adenocarcinoma cell line
L. Bini, Department of Molecular Biology, University of Siena
11.55 - 12.15 Proteome analysis used in the discovery of molecular mechanisms involved in the pathogenesis of type 1 diabetes mellitus
(View Abstract)
T. Sparre, Steno Diabetes Center, Gentofte, Denmark
12.15 - 13.00 Invited Lecture: A Novel Ultra-Sensitive Microarray Platform for Low-Abundant Protein Analysis on Chips
M. Pawlak, Zeptosens, Bioanalytical Solutions, Witterswil, Switzerland
13.00 - 14.00 LUNCH
14.00 - 14.45 Closing Lecture: New Approaches and Applications of Mass Spectrometric Proteome Analysis with High Resolution and High Selectivity
M. Przybylski, Department of Chemistry, University of Konstanz, Germany
14.45 - 15.00 Closing Ceremony (SPS Committee)


ProteomeValley Technology Fair


Scientific Realities & Business Opportunities - Auditorium Marcel Jenny
Session Chairman: Anton Affentranger, Partner Lombard Odier & Cie
15.00 - 15.30 Industrial-scale proteomics at GeneProt
K. Rose, Chief Scientific Officer, GeneProt, Geneva, Switzerland
15.30 - 16.00 From the bench to the "real world": Unprecedented opportunities for scientific discoveries and financial growth
S. Catsicas, Vice president, Research, Swiss Federal Institute of Technology, Lausanne, Switzerland
16.00 - 16.20 Moderated discussion
16.20 - 16.40 COFFEE BREAK

Practical Business Issues
.
A - Business Creation & Development Issues Auditorium Marcel Jenny
Session Chairman: TBA
16.40 - 17.10

Intellectual Property and Licencing Issues
E. G. Lebel, IP Department, Syngenta Crop Protection, Basel, Switzerland

17.10 - 17.40 Business development issues: The road to success
B. Meylan, Senior Manager Corporate Finance, Ernst & Young, Geneva, Switzerland
17.40 - 18.00 Moderated discussion
.
.
B - Challenges in Mass Spectrometry - Rooms 0911-13
Session Chairman: R. Stöcklin, Atheris Labs, Geneva, Switzerland
16.40 - 18.00

Round table discussion with the participation of representatives from major suppliers and of the following users of MS equipment:
P.-A. Binz
(Swiss Institute of Bioinformatics), G. Boehm (GeneProt), Ph. Bullet (CNRS Strasbourg), E. Quéméneur, (CEA Marcoule), C. Servis (University of Lausanne), F. Vilbois (Serono Pharmaceutical Research Institute)


18.00 - 19.30 FAREWELL COCKTAIL (Courtesy of Novartis Pharma AG)

Last updated: Monday, December 10, 2001


© Swiss Proteomics Society